Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women

É Bajnok, I. Takács, P. Vargha, G. Speer, Z. Nagy, P. Lakatos

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The major determinant for risk of osteoporosis in later life is bone mineral density (BMD) attained during early adulthood. Bone mineral density is a complex trait that is presumably influenced by multiple genes. Interleukin-1 receptor antagonist protein (IL-1RN) is an attractive candidate gene for osteoporosis susceptibility, because IL-1RN completely inhibits the stimulatory effects of interleukin-1 (IL-1) on bone resorption in organ cultures and has been implicated in the pathogenesis of osteoporosis. In addition, the IL-1RN gene contains a variable-number tandem repeat polymorphism (VNTR) in intron 2 with three potential protein-binding sites. Recently, an association has been found between this polymorphism and postmenopausal bone loss in the spine. In this study, we use the previously described IL-1RN polymorphism to test for an association between this polymorphism and bone mineral density in our population of postmenopausal women. There was no correlation between alleles or genotypes and BMD in the 286 subjects. Dividing subjects into osteoporotic and healthy groups (osteoporotics and controls), we found no difference in the distribution of alleles or genotypes between groups. We found no association between IL-1RN alleles or genotypes and BMD either at the lumbar spine or the femoral neck within groups. Our data do not support the hypothesis that this IL-1RN gene VNTR polymorphism has an impact on bone mass in postmenopausal women. Copyright (C) 2000 Elsevier Science Inc.

Original languageEnglish
Pages (from-to)559-562
Number of pages4
JournalBone
Volume27
Issue number4
DOIs
Publication statusPublished - 2000

Fingerprint

Interleukin 1 Receptor Antagonist Protein
Bone Density
Genes
Osteoporosis
Minisatellite Repeats
Alleles
Genotype
Spine
Postmenopausal Osteoporosis
Organ Culture Techniques
Femur Neck
Bone Resorption
Interleukin-1
Protein Binding
Introns
Binding Sites
Bone and Bones
Control Groups
Population

Keywords

  • Bone mineral density (BMD)
  • Interleukin-I receptor antagonist protein (IL-1RN)
  • Osteoporosis
  • Polymorphism

ASJC Scopus subject areas

  • Physiology
  • Hematology

Cite this

@article{bc6dcec7422a4d7f8954b50c94faef43,
title = "Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women",
abstract = "The major determinant for risk of osteoporosis in later life is bone mineral density (BMD) attained during early adulthood. Bone mineral density is a complex trait that is presumably influenced by multiple genes. Interleukin-1 receptor antagonist protein (IL-1RN) is an attractive candidate gene for osteoporosis susceptibility, because IL-1RN completely inhibits the stimulatory effects of interleukin-1 (IL-1) on bone resorption in organ cultures and has been implicated in the pathogenesis of osteoporosis. In addition, the IL-1RN gene contains a variable-number tandem repeat polymorphism (VNTR) in intron 2 with three potential protein-binding sites. Recently, an association has been found between this polymorphism and postmenopausal bone loss in the spine. In this study, we use the previously described IL-1RN polymorphism to test for an association between this polymorphism and bone mineral density in our population of postmenopausal women. There was no correlation between alleles or genotypes and BMD in the 286 subjects. Dividing subjects into osteoporotic and healthy groups (osteoporotics and controls), we found no difference in the distribution of alleles or genotypes between groups. We found no association between IL-1RN alleles or genotypes and BMD either at the lumbar spine or the femoral neck within groups. Our data do not support the hypothesis that this IL-1RN gene VNTR polymorphism has an impact on bone mass in postmenopausal women. Copyright (C) 2000 Elsevier Science Inc.",
keywords = "Bone mineral density (BMD), Interleukin-I receptor antagonist protein (IL-1RN), Osteoporosis, Polymorphism",
author = "{\'E} Bajnok and I. Tak{\'a}cs and P. Vargha and G. Speer and Z. Nagy and P. Lakatos",
year = "2000",
doi = "10.1016/S8756-3282(00)00360-4",
language = "English",
volume = "27",
pages = "559--562",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women

AU - Bajnok, É

AU - Takács, I.

AU - Vargha, P.

AU - Speer, G.

AU - Nagy, Z.

AU - Lakatos, P.

PY - 2000

Y1 - 2000

N2 - The major determinant for risk of osteoporosis in later life is bone mineral density (BMD) attained during early adulthood. Bone mineral density is a complex trait that is presumably influenced by multiple genes. Interleukin-1 receptor antagonist protein (IL-1RN) is an attractive candidate gene for osteoporosis susceptibility, because IL-1RN completely inhibits the stimulatory effects of interleukin-1 (IL-1) on bone resorption in organ cultures and has been implicated in the pathogenesis of osteoporosis. In addition, the IL-1RN gene contains a variable-number tandem repeat polymorphism (VNTR) in intron 2 with three potential protein-binding sites. Recently, an association has been found between this polymorphism and postmenopausal bone loss in the spine. In this study, we use the previously described IL-1RN polymorphism to test for an association between this polymorphism and bone mineral density in our population of postmenopausal women. There was no correlation between alleles or genotypes and BMD in the 286 subjects. Dividing subjects into osteoporotic and healthy groups (osteoporotics and controls), we found no difference in the distribution of alleles or genotypes between groups. We found no association between IL-1RN alleles or genotypes and BMD either at the lumbar spine or the femoral neck within groups. Our data do not support the hypothesis that this IL-1RN gene VNTR polymorphism has an impact on bone mass in postmenopausal women. Copyright (C) 2000 Elsevier Science Inc.

AB - The major determinant for risk of osteoporosis in later life is bone mineral density (BMD) attained during early adulthood. Bone mineral density is a complex trait that is presumably influenced by multiple genes. Interleukin-1 receptor antagonist protein (IL-1RN) is an attractive candidate gene for osteoporosis susceptibility, because IL-1RN completely inhibits the stimulatory effects of interleukin-1 (IL-1) on bone resorption in organ cultures and has been implicated in the pathogenesis of osteoporosis. In addition, the IL-1RN gene contains a variable-number tandem repeat polymorphism (VNTR) in intron 2 with three potential protein-binding sites. Recently, an association has been found between this polymorphism and postmenopausal bone loss in the spine. In this study, we use the previously described IL-1RN polymorphism to test for an association between this polymorphism and bone mineral density in our population of postmenopausal women. There was no correlation between alleles or genotypes and BMD in the 286 subjects. Dividing subjects into osteoporotic and healthy groups (osteoporotics and controls), we found no difference in the distribution of alleles or genotypes between groups. We found no association between IL-1RN alleles or genotypes and BMD either at the lumbar spine or the femoral neck within groups. Our data do not support the hypothesis that this IL-1RN gene VNTR polymorphism has an impact on bone mass in postmenopausal women. Copyright (C) 2000 Elsevier Science Inc.

KW - Bone mineral density (BMD)

KW - Interleukin-I receptor antagonist protein (IL-1RN)

KW - Osteoporosis

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=0033800141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033800141&partnerID=8YFLogxK

U2 - 10.1016/S8756-3282(00)00360-4

DO - 10.1016/S8756-3282(00)00360-4

M3 - Article

VL - 27

SP - 559

EP - 562

JO - Bone

JF - Bone

SN - 8756-3282

IS - 4

ER -